LB Pharmaceuticals Inc Common Stock (LBRX)

LB Pharmaceuticals Inc Common Stock (LBRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.2B; returns 1 day -1.8%, 1 week +5.4%, 1 year +144.5%.

LB Pharmaceuticals Inc (LBRX) is a clinical-stage biopharmaceutical company focused on developing small-molecule therapeutics for neuropsychiatric disorders, specifically targeting the multi-billion dollar schizophrenia and bipolar markets.

Groups LBRX belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Neuroscience
• CNS Disorders
• Pharmaceuticals
• Neurological Disorders
• Clinical Stage

LBRX financial model: income statement, cash flow and balance sheet